UWCCC Molecular Tumor Board Registry

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT03023202
Status
Recruiting
Apply to this trial

Conditions

  • Hematologic Neoplasms
  • Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PMMTB (Precision Medicine Molecular Tumor Board) — OTHER
    PMMTB is a clinical intervention, NOT a research intervention. The research component of this study is to observe the outcomes of the PMMTB.

Study Details

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Key Dates

Start date
Mar 30, 2016
Status verified
Apr 2026
Primary completion
Mar 31, 2029
Completion
Mar 31, 2029

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: PMMTB
    This study of the PMMTB will include all patients \>= 18 with clinically suspected or histologically confirmed solid or hematological malignancy who will undergo genetic testing of their tumor. All standard of care functions will be performed by standard procedures.

Primary Outcome Measure

Frequency of acceptance of molecular tumor board recommendations [ Time Frame: Up to 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Wisconsin Carbone Cancer CenterMadisonWisconsin53792
Cancer Connect
[email protected]
800-622-8922

Find similar trials in Madison, WI

By research site
University of Wisconsin Carbone Cancer Center· Madison, WI

Related Studies